Wolverine 20: BPC-157 10MG / TB-500 10MG
Wolverine 20 is a research blend of BPC-157 10mg and TB-500 10mg. Preclinical studies investigate their complementary actions in cytoprotection, cell migration, tissue repair, and inflammation modulation across multiple injury models.
Key Research Areas
- • BPC-157 studied for broad cytoprotective effects and accelerated repair in gastrointestinal, tendon, and muscle injury models.
- • TB-500 investigated for actin regulation and facilitation of cell migration during wound healing processes.
- • Combined actions enable research into synergistic effects on inflammation modulation and extracellular matrix remodeling.
- • Supports multi-pathway investigation of tissue regeneration and structural recovery in musculoskeletal and soft tissue injury models.
Product Specifications
| Product |
Wolverine 20 (BPC-157 10mg / TB-500 10mg) |
| CAS Number |
BPC-157: 137525-51-0; TB-500: 885340-08-9 |
| Molecular Formula |
BPC-157: C62H98N16O22; TB-500: C38H68N10O14 |
| Molar Mass |
BPC-157: 1419.56 g/mol; TB-500: 889.02 g/mol |
| Sequence |
BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val; TB-500: Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln |
| Synonyms |
Wolverine 20 Blend; BPC-157; TB-500 |
| Purity |
≥99% (HPLC) |
| Form |
Lyophilized powder |
| Storage |
−20°C (−4°F) long-term; 2–8°C (36–46°F) reconstituted |
| Solubility |
Bacteriostatic water for laboratory use |
All products offered by Premier Research are intended for laboratory research use only. These materials are not for human or veterinary consumption, medical use, diagnostic procedures, or therapeutic applications. Statements on this website are for informational and educational purposes only and have not been evaluated by the U.S. Food and Drug Administration (FDA). By accessing this site, you confirm that you are a qualified researcher or institution representative and agree to use all materials in accordance with applicable laws, regulations, and safety guidelines.